Phio Pharmaceuticals (PHIO) Change in Acquisitions & Divestments (2014 - 2016)
Phio Pharmaceuticals' (PHIO) quarterly Change in Acquisitions & Divestments came in at $2.0 million in Q4 2016, down 42.86% on a QoQ basis from $3.5 million in Q2 2016.
Phio Pharmaceuticals (PHIO) Change in Acquisitions & Divestments (2014 - 2016) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $2.0 million in Q4 2016.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $7.5 million (changed N/A YoY) and the FY2016 annual result came in at $7.5 million, up 200.0% from the prior year.
- Change in Acquisitions & Divestments slipped to $2.0 million in Q4 2016, from $3.5 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $5.0 million in Q4 2014 to a low of $2.0 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.00 Mn |
| Dec 31, 2016 | 2.00 Mn |
| Jun 30, 2016 | 3.50 Mn |
| Jun 30, 2016 | 3.50 Mn |
| Mar 31, 2016 | 2.00 Mn |
| Mar 31, 2016 | 2.00 Mn |
| Dec 31, 2014 | 5.00 Mn |
| Dec 31, 2014 | 5.00 Mn |